Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q6P1N9
UPID:
TATD1_HUMAN
Alternative names:
Hepatocarcinoma high expression protein
Alternative UPACC:
Q6P1N9; B2R5J0; Q8TD02; Q9BY40
Background:
Deoxyribonuclease TATDN1, also known as Hepatocarcinoma high expression protein, plays a pivotal role in DNA processing. It catalyzes the decatenation of kinetoplast DNA, transforming circular DNA molecules into linear forms. This activity is crucial for chromosomal segregation and cell cycle progression, especially during eye development, suggesting its fundamental role in cellular biology.
Therapeutic significance:
Understanding the role of Deoxyribonuclease TATDN1 could open doors to potential therapeutic strategies. Its involvement in key biological processes such as DNA decatenation and chromosomal segregation highlights its potential as a target for therapeutic intervention in diseases where these processes are dysregulated.